SBID:LSINState Bank of India Sponsored GDR RegS Analysis
Data as of 2026-03-14 - not real-time
$114.60
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
State Bank of India is trading at $114.6, sitting just above the identified support of $113.4 but below both the 20‑day ($128.3) and 50‑day ($121.6) simple moving averages, indicating a short‑term pull‑back within a longer‑term bullish framework (price above the 200‑day SMA of $104.7). The RSI of 31.8 points to oversold conditions, while a bearish MACD histogram and a negative MACD line versus a positive signal line suggest lingering downside momentum. Volume is on the rise, reinforcing the bullish trend direction flagged by the model, and the market’s “Greed” sentiment (Fear & Greed Index 72.9) adds a layer of optimism despite the technical mixed signals.
Valuation and fundamentals paint a more nuanced picture: the trailing P/E of 12.7 is well below the industry average of 16.4, and the price‑to‑book ratio of 0.03 signals deep discounting relative to book value. A solid dividend yield of 2.05% with a modest 15% payout ratio underlines dividend sustainability. However, forward‑looking metrics are concerning—forward P/E jumps to nearly 49 and forward EPS is projected to tumble, reflected in analyst target prices around $104, implying expected earnings pressure. Overall, the stock sits at the intersection of attractive valuation and dividend fundamentals but faces short‑term technical headwinds and earnings uncertainty.
Valuation and fundamentals paint a more nuanced picture: the trailing P/E of 12.7 is well below the industry average of 16.4, and the price‑to‑book ratio of 0.03 signals deep discounting relative to book value. A solid dividend yield of 2.05% with a modest 15% payout ratio underlines dividend sustainability. However, forward‑looking metrics are concerning—forward P/E jumps to nearly 49 and forward EPS is projected to tumble, reflected in analyst target prices around $104, implying expected earnings pressure. Overall, the stock sits at the intersection of attractive valuation and dividend fundamentals but faces short‑term technical headwinds and earnings uncertainty.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold RSI suggesting near‑term upside
- Support level just below current price
- Increasing volume supporting a potential bounce
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward earnings compression reflected in high forward P/E
- Analyst target price below current market level
- Stable dividend yield providing income while earnings normalize
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong ROE (~19%) and solid profit margins
- Deep discount to book value and low trailing P/E versus peers
- Sustained dividend payout with low payout ratio
Key Metrics & Analysis
Financial Health
Revenue Growth48.80%
Profit Margin24.79%
P/E Ratio12.7
ROE19.16%
ROA1.21%
P/B Ratio0.0
Industry P/E16.4
Technical Analysis
TrendBullish
RSI31.8
Support$113.40
Resistance$138.00
MA 20$128.31
MA 50$121.62
MA 200$104.75
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price$104.30
Upside/Downside-8.99%
GradeUndervalued
TypeValue
Dividend Yield2.05%
Risk Assessment
Beta0.14
Volatility41.10%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.